Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Arsenic trioxide - Biosenic

Next Previous
X
Search
Drug Profile

Arsenic trioxide - Biosenic

Alternative Names: ArsciCor; ArsciMed; Arscimed; OATO - Biosenic

Latest Information Update: 30 Oct 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Medsenic
  • Developer Medsenic; Nantes University Hospital; Phebra
  • Class Anti-inflammatories; Antineoplastics; Arsenicals; Ischaemic heart disorder therapies; Oxides; Skin disorder therapies; Small molecules
  • Mechanism of Action Apoptosis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Graft-versus-host disease
  • New Molecular Entity No

Highest Development Phases

  • Phase II Graft-versus-host disease; Systemic lupus erythematosus
  • Preclinical Encephalomyelitis; Multiple sclerosis; Systemic scleroderma

Most Recent Events

  • 28 Oct 2024 Biosenic plans a phase IIb trial for Systemic lupus erythematosus in 2025
  • 28 Oct 2024 Biosenic plans a phase IIb trial for Systemic scleroderma in 2025
  • 14 Aug 2024 Medsenic has patent protection for arsenic trioxide for the treatment of Multiple sclerosis in European Union and USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top